{"id":"CHEMBL1076263","canonicalSmiles":"CS(=O)(=O)Nc1ccc2c(c1)S(=O)(=O)N=C(C1=C(O)[C@@H]3[C@H]4CC[C@H](C4)[C@@H]3N(Cc3ccc(F)cc3)C1=O)N2","inchiKey":"DEKOYVOWOVJMPM-RLHIPHHXSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SETROBUVIR","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ANA-598","ANA598","RO-5466731","RO5466731","Setrobuvir"],"crossReferences":{"Wikipedia":["Setrobuvir"],"drugbank":["DB12051"]},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL1161633","canonicalSmiles":"[O-][Cl+2]([O-])O","inchiKey":"XTEGARKTQYYJKE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHLORATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Chlorate"],"crossReferences":{"drugbank":["DB14150"],"chEBI":["17322"]},"childChemblIds":["CHEMBL1559268","CHEMBL3188561"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1200659","canonicalSmiles":"CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)O.O=C(O)/C=C\\C(=O)O","inchiKey":"OYFJQPXVCSSHAI-QFPUQLAESA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"ENALAPRIL MALEATE","yearOfFirstApproval":1985,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL578","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Ednyt","Enalapril maleate","Enapren","Epaned","Epaned kit","Innovace","Pralenal 10","Pralenal 2.5","Pralenal 20","Pralenal 5","Renitec","Vasotec","Xanef"],"synonyms":["Enalapril maleate","MK-421","NSC-758143"],"crossReferences":{"DailyMed":["enalapril%20maleate"],"PubChem":["56424090","855584"],"chEBI":["4785"]},"linkedTargets":{"rows":["ENSG00000159640"],"count":1},"linkedDiseases":{"rows":["EFO_0000685","MONDO_0001134","EFO_0003144","HP_0000093","EFO_0005669","EFO_0000373","EFO_0000668","EFO_0000537"],"count":8},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1985 and has 3 approved and 4 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1200693","drugType":"Small molecule","blackBoxWarning":false,"name":"MANGANESE CHLORIDE","yearOfFirstApproval":1986,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["CMC-001","CMC001","Manganese chloride","Manganese chloride tetrahydrate","NSC-9879"],"crossReferences":{"Wikipedia":["Manganese(II)_chloride"],"chEBI":["63041"]},"childChemblIds":["CHEMBL1200548"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1986 and has 4 investigational indications."}
{"id":"CHEMBL1200736","canonicalSmiles":"O=C([O-])[O-].[Mg+2]","inchiKey":"ZLNQQNXFFQJAID-UHFFFAOYSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"MAGNESIUM CARBONATE","yearOfFirstApproval":1990,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Andrews","Mag carb","Mag carb arom","Mag carb co","Magnesite"],"synonyms":["Anhydrous magnesium carbonate","C.I. 77713","E-504(i)","E504","Ins no.504(i)","Ins-504(i)","Light magnesium carbonate","Magnesia carbonica","Magnesite (mg(co3))","Magnesium (as carbonate)","Magnesium carbonate","Magnesium carbonate anhydrous","Magnesium carbonate gold star","Magnesium carbonate light","Magnesium carbonate, heavy","Magnesium carbonate, light","NSC-83511"],"crossReferences":{"DailyMed":["magnesium%20carbonate"],"DrugCentral":["4288"],"Wikipedia":["Magnesium_carbonate"],"drugbank":["DB09481"],"chEBI":["31793"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1990 and is indicated for constipation."}
{"id":"CHEMBL1200796","canonicalSmiles":"O.O=P1(N(CCCl)CCCl)NCCCO1","inchiKey":"PWOQRKCAHTVFLB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CYCLOPHOSPHAMIDE","yearOfFirstApproval":1959,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL88","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cyclophosphamide","Cytoxan","Cytoxan (lyophilized)","Endoxana","Lyophilized cytoxan","Neosar"],"synonyms":["B-518","Ciclofosfamide","Cycloblastin","Cyclophosphamide","Cyclophosphamide anhydrous","Cyclophosphamide hydrate","Cyclophosphamide monohydrate","Cyclophosphamidum","Cyclophosphanum","Cyclostin","Cytophosphan","Cytophosphane","Endoxan","Endoxan monohydrate","NSC-26271","NSC-756711","Procytox","Revimmune"],"crossReferences":{"PubChem":["144203651","144208701","144210847","170464624","17389078","26747956","50086596"],"chEBI":["4026"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1959 and has 10 approved and 224 investigational indications."}
{"id":"CHEMBL1200909","canonicalSmiles":"CC(C)(C)CC(=O)OCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C","inchiKey":"HUMXXHTVHHLNRO-KAJVQRHHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PREDNISOLONE TEBUTATE","yearOfFirstApproval":1956,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Hydeltra-tba","Prednisolone tebutate"],"synonyms":["Anhydrous prednisolone tebutate","Prednisolone butylacetate","Prednisolone tebutate"],"crossReferences":{"PubChem":["170465430"],"drugbank":["DB14632"],"chEBI":["8381"]},"linkedTargets":{"rows":["ENSG00000113580"],"count":1},"linkedDiseases":{"rows":["EFO_0009552","HP_0001742","HP_0004798","EFO_0005752"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1956 and has 3 approved indications."}
{"id":"CHEMBL1200916","canonicalSmiles":"CSc1ccc2c(c1)N(CCC1CCCCN1C)c1ccccc1S2.Cl","inchiKey":"NZFNXWQNBYZDAQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"THIORIDAZINE HYDROCHLORIDE","yearOfFirstApproval":1962,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL479","hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["United Kingdom"," Worldwide"],"classes":["Cardiotoxicity"],"year":2005},"tradeNames":["Mellaril","Thioridazine hydrochloride","Thioridazine hydrochloride intensol"],"synonyms":["NSC-186060","Thioridazine hcl","Thioridazine hydrochloride"],"crossReferences":{"DailyMed":["thioridazine%20hydrochloride"],"PubChem":["144209999","26747699","26747700","50107199","50107200","50107201","56422406","855568"],"chEBI":["48566"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1962. It was withdrawn in United Kingdom and  Worldwide initially in 2005 due to Cardiotoxicity. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1200936","canonicalSmiles":"CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O.CCN(CC)CCOC(=O)c1ccc(N)cc1.O","inchiKey":"KZDCMKVLEYCGQX-UDPGNSCCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PENICILLIN G PROCAINE","yearOfFirstApproval":1948,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1628385","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Crysticillin","Duracillin","Duracillin a.s.","Penicillin g procaine","Pfizerpen","Pfizerpen-as","Procaine Penicillin","Wycillin"],"synonyms":["Benzylpenicillin procaine","Crysticillin a.s.","Penicillin g procaine","Procaine Benzylpenicillin","Procaine penicillin","Procaine penicillin g","Procaini benzylpenicillinum"],"crossReferences":{"DailyMed":["penicillin%20g%20procaine"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1948 and is indicated for infection and has 3 investigational indications."}
{"id":"CHEMBL1201098","canonicalSmiles":"CO[C@@]1(NC(=O)C2SC(=C(C(N)=O)C(=O)[O-])S2)C(=O)N2C(C(=O)[O-])=C(CSc3nnnn3C)CS[C@@H]21.[Na+].[Na+]","inchiKey":"ZQQALMSFFARWPK-GLHLDKNHSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"CEFOTETAN DISODIUM","yearOfFirstApproval":1985,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL474579","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cefotan","Cefotetan","Yamatetan"],"synonyms":["Cefotetan disodium","Cefotetan disodium salt","Cefotetan sodium","YM-09330"],"crossReferences":{"DailyMed":["cefotetan%20disodium"],"chEBI":["34617"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1985 and is indicated for infection and has 1 investigational indication."}
{"id":"CHEMBL1201233","canonicalSmiles":"CCOC(=O)[C@@](C)(N)Cc1ccc(O)c(O)c1","inchiKey":"SVEBYYWCXTVYCR-LBPRGKRZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"METHYLDOPATE","yearOfFirstApproval":1962,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Methyldopate"],"childChemblIds":["CHEMBL1200432"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1962."}
{"id":"CHEMBL1201289","canonicalSmiles":"CCCCCCCCCCCCCCCC(=O)O[C@@H]1[C@@H](O)[C@@H](O)[C@@H]([C@H](NC(=O)[C@@H]2C[C@@H](CCC)CN2C)[C@H](C)Cl)O[C@@H]1SC","inchiKey":"OYSKUZDIHNKWLV-PRUAPSLNSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"CLINDAMYCIN PALMITATE","yearOfFirstApproval":1986,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Clindamycin palmitate"],"crossReferences":{"DailyMed":["clindamycin%20palmitate%20hydrochloride"]},"childChemblIds":["CHEMBL1200632"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1986 and is indicated for infection and acne and has 1 investigational indication. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1201581","drugType":"Antibody","blackBoxWarning":true,"name":"INFLIXIMAB","yearOfFirstApproval":1998,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Inflectra","Remicade","Remsima"],"synonyms":["ABP 710","Abp-710","Avsola","BOW015","Bow-015","Ct-p-13","Ct-p13","Infimab","Infliximab","Infliximab (janssen)","Infliximab (remicade)","Infliximab-abda","Infliximab-axxq","Infliximab-dyyb","Infliximab-hjmt","Infliximab-pfizer","Infliximab-qbtx","Ixifi","NI-071","Pf-06438179","TA-650","Zessly","cA2"],"crossReferences":{"DailyMed":["infliximab","infliximab-abda","infliximab-axxq","infliximab-dyyb"],"DrugCentral":["4974"],"Wikipedia":["Infliximab"]},"linkedTargets":{"rows":["ENSG00000232810"],"count":1},"linkedDiseases":{"rows":["EFO_0000729","EFO_0004683","EFO_1000710","EFO_0003780","EFO_0000756","EFO_1000747","EFO_0000540","MONDO_0008903","EFO_0000783","EFO_0000676","EFO_0004616","HP_0003419","HP_0012378","EFO_0004276","EFO_1000749","Orphanet_379","EFO_0000198","MONDO_0013730","EFO_1001857","EFO_0002687","HP_0002039","EFO_0007168","EFO_0000384","EFO_1000784","EFO_0004232","EFO_1001209","MONDO_0019474","EFO_1001231","EFO_0007460","MONDO_0100096","MONDO_0003937","EFO_0000398","HP_0004326","EFO_0000341","EFO_0000516","EFO_0003767","MONDO_0005090","EFO_0001065","EFO_0003778","EFO_0004246","MONDO_0001718","EFO_0008518","EFO_0000289","MONDO_0002050","EFO_0003047","EFO_0009321","EFO_0007527","EFO_0002617","Orphanet_797","EFO_0000685","EFO_0003898","EFO_0004599","EFO_0002609","EFO_0000537","EFO_0004220","EFO_0005297","MONDO_0005147","EFO_0000706","MONDO_0005178","EFO_0004775","EFO_0003872"],"count":61},"description":"Antibody drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1998 and has 7 approved and 44 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1212979","canonicalSmiles":"Nc1ncnc2c1ncn2[C@@H]1O[C@H](CF)[C@@H](O)[C@H]1O","inchiKey":"QPVLKMICBYRPSX-KQYNXXCUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1212979","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03716"],"chEBI":["12060"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1232903","canonicalSmiles":"O=P(O)(O)OC(CO)CO","inchiKey":"DHCLVCXQIBBOPH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GLYCERYLPHOSPHATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Glycerophosphate","Glycerophosphoric acid","Glyceryl phosphate"],"crossReferences":{"PubChem":["29217795"],"drugbank":["DB01779"],"chEBI":["17270"]},"childChemblIds":["CHEMBL3707206"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1234490","canonicalSmiles":"CCNc1nc(NC(C)(C)C)nc(SC)n1","inchiKey":"IROINLKCQGIITA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TERBUTRYNE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144209280","144213458","26757718","47193751"],"drugbank":["DB08215"],"chEBI":["44156"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1235346","canonicalSmiles":"O=C(O)c1cc(C(=O)O)c(C(=O)O)cc1C(=O)O","inchiKey":"CYIDZMCFTVVTJO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PYROMELLITIC ACID","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["1,2,4,5-Benzenetetracarboxylic Acid"],"crossReferences":{"PubChem":["144212347"],"drugbank":["DB02749"],"chEBI":["45165"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1236936","canonicalSmiles":"O=C(O)CCCCN(CCc1ccccc1OCc1ccc(CCc2ccccc2)cc1)Cc1ccc(C(=O)O)cc1","inchiKey":"WPYWMXNXEZFMAK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CINACIGUAT","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BAY 58-2667","Cinaciguat"],"linkedTargets":{"rows":["ENSG00000164116","ENSG00000061918","ENSG00000123201","ENSG00000152402"],"count":4},"linkedDiseases":{"rows":["EFO_0003144","EFO_0000373"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL135","canonicalSmiles":"C[C@]12CC[C@@H]3c4ccc(O)cc4CC[C@H]3[C@@H]1CC[C@@H]2O","inchiKey":"VOXZDWNPVJITMN-ZBRFXRBCSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"ESTRADIOL","yearOfFirstApproval":1975,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Adgyn estro","Alora","Aquagen","Bedol","Climara","Climara Pro","Dermestril 100","Dermestril 25","Dermestril 50","Dermestril septem 25","Dermestril septem 50","Dermestril septem 75","Divigel","E-Cypionate","Elestrim","Elestrin","Elleste solo","Elleste solo mx 40","Elleste solo mx 80","Esclim","Estrace","Estraderm","Estraderm mx 100","Estraderm mx 25","Estraderm mx 50","Estraderm mx 75","Estraderm tts 100","Estraderm tts 25","Estraderm tts 50","Estradiol","Estrasorb","Estring","Estrogel","Evamist","Evorel 100","Evorel 25","Evorel 50","Evorel 75","Fematrix 40","Fematrix 80","Fempatch","Femseven 100","Femseven 50","Femseven 75","Gvnodiol","Gynodiol","Gynogen","Imvexxy","Innofem","Menorest 37.5","Menorest 50","Menorest 75","Menoring 50","Menostar","Minivelle","Oestradiol","Progynova ts","Sandrena","Vagifem","Vagifem 18","Vagifem 8","Vivelle","Vivelle-dot","Zumenon"],"synonyms":["17-.beta.-oestradiol","17-beta-oestradiol","17.beta.-estradiol","17beta-estradiol","Agofollin","Alfatradiol","Depo-Estradiol","Destradiol","Dihydrotheelin","Dihydroxyestrin","Estradiol","Estradiol 17-beta","Estradiol anhydrous","Estradiol hemihydrate","Estradiol valerate metabolite e2","Estrasorb","Gynergon","Gynoestryl","NSC-20293","NSC-9895","Oestradiol","WC-3011","WC3011"],"crossReferences":{"DailyMed":["estradiol"],"PubChem":["144204699","144209255","144210608","17389898","26753050","26753051","26753052","29215115","29215116","29215117","50105619","50105620","50124031","56422158","8139865","90341590"],"Wikipedia":["Estradiol"],"drugbank":["DB00783"],"chEBI":["16469"]},"linkedTargets":{"rows":["ENSG00000091831"],"count":1},"linkedDiseases":{"rows":["EFO_0003869","HP_0031217","EFO_1001271","EFO_0003914","HP_0000938","EFO_0003103","EFO_0004714","HP_0008209","EFO_0010270","EFO_0000400","Orphanet_145","EFO_1000906","EFO_0000180","EFO_0009867","HP_0030016","MONDO_0008315","EFO_0000660","EFO_0001663","MP_0001914","GO_0007568","MONDO_0100096","EFO_0000731","HP_0100607","Orphanet_881","EFO_1000859","EFO_0003922","EFO_0004320","EFO_0005204","MONDO_0005090","MONDO_0001410","EFO_0001065","EFO_0009006","EFO_0007453","MONDO_0007254","EFO_1001249","HP_0000132","EFO_0003882","EFO_0000305","EFO_0002950","MONDO_0005277","MONDO_0002146","MONDO_0041161","MONDO_0002050","HP_0002907","EFO_1001375","EFO_1000645","EFO_1000096","EFO_0004215","EFO_0000545","EFO_1001757","EFO_0009315","EFO_0001358","EFO_0000319","EFO_0004243","EFO_0001073","EFO_0003843","EFO_0000537","EFO_0010269","MONDO_0005301","EFO_0009851","EFO_0000764","MONDO_0005147","MONDO_0004975","EFO_1000766","MONDO_0005148","EFO_0005411","EFO_0004710"],"count":67},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1975 and has 3 approved and 45 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1363","canonicalSmiles":"COc1ccc(C[C@@H](C)NC[C@H](O)c2ccc(O)c(NC=O)c2)cc1","inchiKey":"BPZSYCZIITTYBL-YJYMSZOUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ARFORMOTEROL","yearOfFirstApproval":2006,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Arformoterol","Formoterol r,r-form"],"crossReferences":{"DailyMed":["arformoterol%20tartrate"],"Wikipedia":["Formoterol"],"drugbank":["DB01274"],"chEBI":["408174"]},"childChemblIds":["CHEMBL3184383","CHEMBL605993","CHEMBL1200811","CHEMBL1951071"],"linkedTargets":{"rows":["ENSG00000169252"],"count":1},"linkedDiseases":{"rows":["EFO_0000464","EFO_0006505","EFO_0009661","MONDO_0004979","EFO_0000341","HP_0025428"],"count":6},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2006 and has 3 approved and 6 investigational indications."}
{"id":"CHEMBL139020","canonicalSmiles":"O=C(O)Cc1cccc([N+](=O)[O-])c1","inchiKey":"WUKHOVCMWXMOOA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL139020","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08193"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1420319","canonicalSmiles":"CC(C)(C)c1ccc(Oc2ccc(N)cn2)cc1","inchiKey":"WHIWGRCYMQLLAO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CB-103","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CB-103","Cb-103"],"crossReferences":{"PubChem":["26730448"],"drugbank":["DB15279"]},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL1439973","canonicalSmiles":"CC(C)(O)C(Cl)(Cl)Cl","inchiKey":"OSASVXMJTNOKOY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHLOROBUTANOL","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Chloretone"],"synonyms":["Anhydrous chlorobutanol","Chlorbutol","Chlorobutanol","Chlorobutanol, anhydrous","Chlorobutanolum","NSC-44794","Trichlorisobutylalcohol"],"crossReferences":{"PubChem":["144205182","170465458","29215323","29215324"],"drugbank":["DB11386"]},"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for nausea."}
{"id":"CHEMBL1441059","canonicalSmiles":"CC(C)(C)NCC(O)c1ccc(O)c(CO)c1.CC(C)(C)NCC(O)c1ccc(O)c(CO)c1.O=S(=O)(O)O","inchiKey":"BNPSSFBOAGDEEL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"ALBUTEROL SULFATE","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL714","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Accuneb","Albuterol sulfate","Proair","Proair digihaler","Proair hfa","Proair respiclick","Proventil","Proventil-hfa","Ventolin","Ventolin hfa","Ventolin rotacaps","Volmax","Vospire er"],"synonyms":["Albuterol sulfate","Albuterol sulphate","Buventol","Ecovent","Loftan","NSC-289928","R03AC02","R03CC02","SCH 13949W SULFATE","SCH-13949W SULFATE","Salamol","Salbumol","Salbutamol (as sulfate)","Salbutamol sulfate","Salbutamol sulphate","Salbutamoli sulfas","Sch 13949w sulphate","Sch-13949w sulphate","Sulbutamol (as sulphate)","Sultanol","Torpex","Venetlin","Ventilastin","Vospire"],"crossReferences":{"DailyMed":["albuterol%20sulfate"],"PubChem":["50107002"]},"linkedTargets":{"rows":["ENSG00000169252"],"count":1},"linkedDiseases":{"rows":["MONDO_0100130","EFO_0008590","EFO_0010638","MONDO_0100053","MONDO_0004979","EFO_0000341","HP_0025428","EFO_0000319","EFO_0003818","MONDO_0004784"],"count":10},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1982 and has 3 approved and 4 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL146506","canonicalSmiles":"C/C(=C\\c1ccc(OCCN2CCOCC2)cc1)c1ccc2c(c1)C(C)(C)CCC2(C)C","inchiKey":"OUQPTBCOEKUHBH-LSDHQDQOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MOFAROTENE","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Mofarotene","RO 40-8757","Ro-408757"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL14687","canonicalSmiles":"CCCO","inchiKey":"BDERNNFJNOPAEC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PROPANOL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ethylcarbinol","Propan-1-ol","Propanol"],"crossReferences":{"Wikipedia":["1-Propanol"],"drugbank":["DB03175"],"chEBI":["28831"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL14762","canonicalSmiles":"CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1","inchiKey":"BTIHMVBBUGXLCJ-OAHLLOKOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SELICICLIB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AL-39256","CYC-202","Cyc-202","NSC-701554","R-roscovitine","Roscovitin","Roscovitine","Seliciclib"],"crossReferences":{"PubChem":["124891685","26753649","26753650","50100113","50107006","527377"],"Wikipedia":["Seliciclib"],"drugbank":["DB06195"],"chEBI":["45307"]},"linkedTargets":{"rows":["ENSG00000123374","ENSG00000134058","ENSG00000164885","ENSG00000136807","ENSG00000170312"],"count":5},"linkedDiseases":{"rows":["EFO_0000616","MONDO_0007254","Orphanet_586","EFO_1001110","EFO_0003060"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL1496","canonicalSmiles":"CC(C)c1nc(N(C)S(C)(=O)=O)nc(-c2ccc(F)cc2)c1/C=C/[C@@H](O)C[C@@H](O)CC(=O)O","inchiKey":"BPRHUIZQVSMCRT-VEUZHWNKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ROSUVASTATIN","yearOfFirstApproval":2003,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Creston","Rosuvastatin","X-plended","ZD-4522","ZD4522"],"crossReferences":{"DailyMed":["rosuvastatin%20calcium"],"Wikipedia":["Rosuvastatin"],"drugbank":["DB01098"],"chEBI":["38545"]},"childChemblIds":["CHEMBL1744447"],"linkedTargets":{"rows":["ENSG00000113161"],"count":1},"linkedDiseases":{"rows":["EFO_0000729","MONDO_0001583","EFO_0009505","EFO_0000275","EFO_1000657","EFO_0005669","EFO_0000266","EFO_0000540","HP_0100545","EFO_1001951","EFO_0003913","EFO_0003964","EFO_0003914","EFO_0004714","EFO_0008585","EFO_0002690","EFO_1000807","Orphanet_391665","EFO_0000400","EFO_0000407","HP_0003124","EFO_0002687","HP_0001685","MONDO_0008170","EFO_0000180","EFO_0004286","EFO_0000701","EFO_1001512","EFO_0009516","EFO_0000384","Orphanet_95","MONDO_0008315","Orphanet_309005","EFO_0004239","HP_0100806","EFO_0009426","MONDO_0100096","MONDO_0021187","Orphanet_412","EFO_1000049","EFO_0003907","MONDO_0004979","EFO_0000341","MONDO_0001641","EFO_0000668","EFO_0005672","EFO_0009878","EFO_0003086","EFO_1001454","MONDO_0007254","EFO_1001249","EFO_1001413","EFO_0000373","EFO_1001461","EFO_1002048","Orphanet_91378","EFO_0004211","HP_0000083","EFO_0600064","MONDO_0041161","EFO_0005226","MONDO_0002050","EFO_0003144","EFO_0000712","MONDO_0005180","EFO_0000673","EFO_0004272","EFO_0004826","EFO_0003047","EFO_0000717","EFO_0002617","EFO_0000616","EFO_0000685","HP_0002140","EFO_0001645","EFO_0009783","EFO_0000556","EFO_0000319","EFO_0001073","EFO_0003060","EFO_0004911","EFO_0000537","EFO_0000311","EFO_0000195","EFO_0000589","EFO_1001150","EFO_0001068","MONDO_0021661","EFO_0000649","EFO_0000764","MONDO_0005147","Orphanet_79211","EFO_0008583","EFO_0000612","MONDO_0005148","EFO_0003918"],"count":96},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2003 and has 7 approved and 80 investigational indications."}
{"id":"CHEMBL150261","canonicalSmiles":"N[C@H]1CC[C@H](Nc2nc(NCc3ccccc3)c3ncn(C4CCCC4)c3n2)CC1","inchiKey":"JTVILUUAQWQWBK-IYARVYRRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL150261","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04288"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1733174","canonicalSmiles":"CCOc1cc(N)c(Cl)cc1C(=O)NCC1CN(Cc2ccc(F)cc2)CCO1.O=C(O)CC(O)(CC(=O)O)C(=O)O","inchiKey":"HUZTYZBFZKRPFG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MOSAPRIDE CITRATE","maximumClinicalTrialPhase":3,"parentId":"CHEMBL60889","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AS-4370","Gasmotin","Mosapride citrate","Rimopride citrate"],"crossReferences":{"PubChem":["144205427","170466008","49681606"]},"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL1738757","canonicalSmiles":"CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3cc(C(C)(C)C)nn3-c3ccc4ncccc4c3)c(F)c2)ccn1","inchiKey":"WVXNSAVVKYZVOE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"REBASTINIB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Dp-1919"],"synonyms":["DCC-2036","DCC-2036 FREE BASE","DP-1919","Dcc-2036","Rebastinib"],"crossReferences":{"PubChem":["137276016"],"drugbank":["DB13005"],"chEBI":["62166"]},"childChemblIds":["CHEMBL2107833"],"linkedTargets":{"rows":["ENSG00000097007"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","EFO_0000304","EFO_0000339"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL1743028","drugType":"Antibody","blackBoxWarning":false,"name":"GLEMBATUMUMAB VEDOTIN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CDX-011","CR-011-VCMMAE","Glembatumumab vedotin"],"linkedTargets":{"rows":["ENSG00000261456","ENSG00000188229","ENSG00000104833","ENSG00000137267","ENSG00000258947","ENSG00000101162","ENSG00000136235","ENSG00000196230","ENSG00000137285","ENSG00000176014"],"count":10},"linkedDiseases":{"rows":["EFO_0000637","EFO_1000616","EFO_0000756","MONDO_0007254","EFO_0000708"],"count":5},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL176072","canonicalSmiles":"CN(C)c1cccc2c(S(=O)(=O)N[C@@H](Cc3ccc(OS(=O)(=O)c4cccc5c(N(C)C)cccc45)cc3)C(=O)O)cccc12","inchiKey":"LUBOPDUYHWABFG-NDEPHWFRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL176072","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03157"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL178938","canonicalSmiles":"CNCc1ccc(-c2cccnc2)o1","inchiKey":"MDGMPFRIYUFRRX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL178938","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07617"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL194009","canonicalSmiles":"Nc1ncccc1OCc1ccccc1","inchiKey":"NMCBWICNRJLKKM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL194009","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02352"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL198877","canonicalSmiles":"Oc1ccc([C@H]2COc3cc(O)ccc3C2)cc1","inchiKey":"ADFCQWZHKCXPAJ-GFCCVEGCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AUS-131","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["(S)-Equol","Aus-131"],"crossReferences":{"Wikipedia":["Equol"],"drugbank":["DB11674"],"chEBI":["34741"]},"linkedTargets":{"rows":["ENSG00000140009"],"count":1},"linkedDiseases":{"rows":["MONDO_0004975","MONDO_0007254","EFO_0000284","EFO_0003922"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL2023895","canonicalSmiles":"N=C(N)c1ccc(/C=C/c2ccc(C(=N)N)cc2O)cc1.O=S(=O)(O)CCO.O=S(=O)(O)CCO","inchiKey":"XVTQTNAKZYLTNZ-HFPMQDOPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"HYDROXYSTILBAMIDINE ISETHIONATE","yearOfFirstApproval":1953,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1301","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Hydroxystilbamidine isethionate"],"synonyms":["Hydroxystilbamidine isethionate","NSC-259242","Oxistilbamidine isethionate"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1953."}
{"id":"CHEMBL2068237","drugType":"Small molecule","blackBoxWarning":true,"name":"CISPLATIN","yearOfFirstApproval":1978,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144204562","144207019","144209698","170464726"],"TG-GATEs":["132"]},"childChemblIds":["CHEMBL11359"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1978 and is indicated for neoplasm and cancer and has 173 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL2104445","canonicalSmiles":"CCOc1c(N)c2c(c(OCC)c1OCC)C(C1c3c(cc4c(c3OC)OCO4)CCN1C)OC2=O","inchiKey":"IRGJVQIJENCTQF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TRITOQUALINE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Hypostamine"],"synonyms":["Hypostamin","Inhibostamin","L-554","Livalfa","MCI-5011","Tritocaline","Tritoqualine"],"crossReferences":{"drugbank":["DB13711"]},"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for allergic disease."}
{"id":"CHEMBL2104462","canonicalSmiles":"COc1ccc2c(=O)c3ccccc3oc2c1CN1CCCCC1","inchiKey":"PYSOHOOUXFWCFF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MEPIXANOX","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Mepixanox"],"crossReferences":{"drugbank":["DB13579"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2104786","canonicalSmiles":"CC(C)(CO)[C@@H](O)C(=O)NCCC(=O)NCCSSCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)CO","inchiKey":"DJWYOLJPSHDSAL-ROUUACIJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PANTETHINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["D-pantethine","NSC-759269","Pantethine"],"crossReferences":{"drugbank":["DB11190"],"chEBI":["31959"]},"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL2104962","canonicalSmiles":"Cc1ccc(S(=O)(=O)O)cc1.N#C[C@@H]1C[C@H](F)CN1C(=O)[C@@H](N)C(c1ccc(F)cc1)c1ccc(F)cc1","inchiKey":"MSCWUTTUQLYJFT-QMBKNIKNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DENAGLIPTIN TOSYLATE","maximumClinicalTrialPhase":2,"parentId":"CHEMBL2110666","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Denagliptin tosilate","Denagliptin tosylate","GW-823093C","GW823093C"],"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2104970","canonicalSmiles":"NC(=O)C1=C(O)C[C@@H]2C[C@@H]3Cc4cccc(O)c4C(=O)C3=C(O)[C@]2(O)C1=O","inchiKey":"ZXFCRFYULUUSDW-OWXODZSWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"INCYCLINIDE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Metastat"],"synonyms":["COL-3","Incyclinide","NSC-683551"],"crossReferences":{"drugbank":["DB11647"]},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2105359","canonicalSmiles":"C=C1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO","inchiKey":"WSVOMANDJDYYEY-CWNVBEKCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PREDNYLIDENE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Methylenprednisolone","Prednylidene"],"crossReferences":{"drugbank":["DB13208"]},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2105758","canonicalSmiles":"O=C(Nc1nc(-c2cc(Cl)cs2)c(N2CCN(C3CCCCC3)CC2)s1)c1cnc(N2CCC(C(=O)O)CC2)c(Cl)c1.O=C(O)/C=C\\C(=O)O","inchiKey":"MISPBGHDNZYFNM-BTJKTKAUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AVATROMBOPAG MALEATE","yearOfFirstApproval":2018,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL2103883","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Doptelet"],"synonyms":["Avatrombopag maleate","E-5501 MALEATE","E5501 MALEATE"],"crossReferences":{"DailyMed":["avatrombopag%20maleate"]},"linkedTargets":{"rows":["ENSG00000117400"],"count":1},"linkedDiseases":{"rows":["EFO_0001421","HP_0001873"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2018 and is indicated for thrombocytopenia and liver disease."}
{"id":"CHEMBL2106399","canonicalSmiles":"CO[C@@H]1[C@@H](O[C@@H]2O[C@H](C)[C@@H](O[C@H]3C[C@@](C)(O)[C@@H](OC(=O)CC(C)C)[C@H](C)O3)[C@H](N(C)C)[C@H]2O)[C@@H](CC=O)C[C@@H](C)[C@@H](O)/C=C/C=C/C[C@@H](C)OC(=O)C[C@H]1O","inchiKey":"IEMDOFXTVAPVLX-YWQHLDGFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"KITASAMYCIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Acetylkitasamycin","Kitasamycin","Kitasamycin tartrate","Leucomycin"],"crossReferences":{"drugbank":["DB09309"],"chEBI":["34812"]},"childChemblIds":["CHEMBL2355304"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2106618","canonicalSmiles":"Cc1cc(C(=O)NCCc2ccc(S(=O)(=O)NC(=O)NN3CCCCCC3)cc2)no1","inchiKey":"ZKUDBRCEOBOWLF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GLISOXEPIDE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BAY B 4231","BAY-B-4231","FBB 4231","FBB-4231","Glisoxepid","Glisoxepide","RP 22410","RP-22410"],"crossReferences":{"PubChem":["144205252"],"drugbank":["DB01289"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2107369","canonicalSmiles":"CC(=O)O.CC(=O)O.CC(C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)CNC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CS)NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CNC(=O)[C@H](C)N)C(N)=O","inchiKey":"FZVMMANVVHMVBM-OIXLVLAFSA-N","drugType":"Protein","blackBoxWarning":false,"name":"RUSALATIDE ACETATE","maximumClinicalTrialPhase":2,"parentId":"CHEMBL2111105","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Chrysalin"],"synonyms":["Rusalatide acetate","Rusalatide acetate (3:2)","TP 508","TP-508 ACETATE","TRAP-508","TRAP-508 ACETATE"],"description":"Protein drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2108512","drugType":"Unknown","blackBoxWarning":false,"name":"HEPATITIS B IMMUNE GLOBULIN","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Bayhep b","H-big","Hep-b-gammagee","Liberim hb"],"synonyms":["Hepabulin","Hepatitis b immune globulin","Hepatitis b immunoglobulin","Human hepatitis b immunoglobulin","Human hepatitis-b immunoglobulin","Hyperhep b","Immunogam","Zutectra"],"description":"Unknown drug with a maximum clinical trial phase of IV (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2108611","drugType":"Antibody","blackBoxWarning":true,"name":"INOTUZUMAB OZOGAMICIN","yearOfFirstApproval":2017,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Besponsa"],"synonyms":["CMC-544","Inotuzumab ozogamicin","PF-05208773","WAY-207294","WAY-207294 CMC-544"],"crossReferences":{"DailyMed":["inotuzumab%20ozogamicin"]},"linkedTargets":{"rows":["ENSG00000012124"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","MONDO_0000873","EFO_0000096","EFO_0000220","EFO_0000403","EFO_0000574","EFO_1000131","MONDO_0018906","EFO_0005952","EFO_0000094","MONDO_0044881"],"count":11},"description":"Antibody drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2017 and has 4 approved and 8 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL2108679","drugType":"Antibody","blackBoxWarning":false,"name":"OZANEZUMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Gsk1223249"],"synonyms":["GSK-1223249","GSK1223249","Ozanezumab"],"linkedTargets":{"rows":["ENSG00000115310"],"count":1},"linkedDiseases":{"rows":["MONDO_0005301","EFO_0003929","MONDO_0004976"],"count":3},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL2108710","drugType":"Unknown","blackBoxWarning":false,"name":"RIMABOTULINUMTOXINB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Myobloc"],"synonyms":["AN-0772","AN0772","BTX-8","BTX-B","Botulin b","Botulinum toxin type b","Rimabotulinumtoxinb"],"description":"Unknown drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL216973","canonicalSmiles":"Nc1cccc2cnccc12","inchiKey":"DTVYNUOOZIKEEX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"5-Aminoisoquinoline","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["5-Aminoisoquinoline"],"crossReferences":{"PubChem":["4248661"],"drugbank":["DB04605"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2181776","canonicalSmiles":"Cn1c(-c2ccccn2)c(C2CCCC2)c2ccc(C(=O)NC3(C(=O)Nc4ccc(/C=C/C(=O)O)cc4)CCC3)cc21","inchiKey":"JBSNALXXNTWUEC-SFQUDFHCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BILB-1941","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BILB 1941","BILB-1941ZW","Bilb-1941"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2218877","canonicalSmiles":"CCC(=O)O[C@H]1[C@H](O[C@@H]2[C@@H](C)[C@H](O[C@H]3C[C@@](C)(OC)[C@@H](O)[C@H](C)O3)[C@@H](C)C(=O)O[C@H](CC)[C@@](C)(O)[C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@]2(C)O)O[C@H](C)C[C@@H]1N(C)C.CCCCCCCCCCCCOS(=O)(=O)O","inchiKey":"AWMFUEJKWXESNL-JZBHMOKNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ERYTHROMYCIN ESTOLATE","yearOfFirstApproval":1967,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL2220427","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Erythromycin estolate","Ilosone"],"synonyms":["Erythromycin (as estolate)","Erythromycin estolate","Erythromycin lauryl sulfate, propionyl","Erythromycin propionate lauryl sulfate","NSC-263364","Propionyl erythromycin lauryl sulfate"],"crossReferences":{"PubChem":["144212546"],"chEBI":["4846"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1967."}
{"id":"CHEMBL2219642","canonicalSmiles":"[Cl-].[Cl-].[Mg+2]","inchiKey":"TWRXJAOTZQYOKJ-UHFFFAOYSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"MAGNESIUM CHLORIDE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Magnesium chloride"],"crossReferences":{"DailyMed":["magnesium%20chloride"],"drugbank":["DB09407"],"chEBI":["6636"]},"childChemblIds":["CHEMBL3185229"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for hemorrhage and has 3 investigational indications."}
{"id":"CHEMBL224282","canonicalSmiles":"Cc1ccc(O)c(N)c1","inchiKey":"ZMXYNJXDULEQCK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL224282","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144207890","17389360","85147155"],"drugbank":["DB04533"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL248643","canonicalSmiles":"Oc1ccc(-c2cnc3ccc4ccncc4c3c2)cc1","inchiKey":"IUSSGTWHFMSCOY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL248643","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03623"],"chEBI":["40444"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL254328","canonicalSmiles":"C[C@]12CC[C@H]3[C@@H](CC=C4C[C@@H](O)CC[C@@]43C)[C@@H]1CC=C2c1cccnc1","inchiKey":"GZOSMCIZMLWJML-VJLLXTKPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ABIRATERONE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Zytiga"],"synonyms":["Abiraterone","CB 7598","CB-7598","NSC-741232"],"crossReferences":{"Wikipedia":["Abiraterone"],"drugbank":["DB05812"],"chEBI":["68642"]},"linkedTargets":{"rows":["ENSG00000148795","ENSG00000277893","ENSG00000128039","ENSG00000145545","ENSG00000169083"],"count":5},"linkedDiseases":{"rows":["EFO_0000616","EFO_0000673","EFO_0000196","MONDO_0008315","EFO_0001663","EFO_0000311"],"count":6},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for cancer and neoplasm and has 4 investigational indications."}
{"id":"CHEMBL267648","canonicalSmiles":"CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCN(C)CC3)cc21","inchiKey":"FHFYDNQZQSQIAI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PEFLOXACIN","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["1589 RB","1589-RB","EU-5306","Pefloxacin"],"crossReferences":{"PubChem":["174006962"],"Wikipedia":["Pefloxacin"],"drugbank":["DB00487"],"chEBI":["50199"]},"childChemblIds":["CHEMBL3763640","CHEMBL1428564"],"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for bacterial disease."}
{"id":"CHEMBL267894","canonicalSmiles":"CCC1(CCC(C)C)C(=O)N=C(O)NC1=O","inchiKey":"VIROVYVQCGLCII-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AMOBARBITAL","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["Norway"],"classes":["Misuse"],"year":1980},"tradeNames":["Amytal"],"synonyms":["Amobarbital","Amobarbital cii","Amylobarbitone","Isomytal","NSC-10815","Pentymal"],"crossReferences":{"PubChem":["144206419"],"Wikipedia":["Amobarbital"],"drugbank":["DB01351"],"chEBI":["2673"]},"childChemblIds":["CHEMBL2105941"],"description":"Small molecule drug with a maximum clinical trial phase of IV and has 1 investigational indication. It was withdrawn in Norway  in 1980 due to Misuse."}
{"id":"CHEMBL281594","canonicalSmiles":"Fc1ccc(C(OCCN2CCN(CCCc3ccccc3)CC2)c2ccc(F)cc2)cc1","inchiKey":"NAUWTFJOPJWYOT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VANOXERINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GBR 12909","GBR-12909","Vanoxerine"],"crossReferences":{"PubChem":["104171142","11111021","11111022","11113492","124879806","26751714","50104404","90341225"],"Wikipedia":["Vanoxerine"],"drugbank":["DB03701"],"chEBI":["64089"]},"childChemblIds":["CHEMBL153260","CHEMBL1973367","CHEMBL542933","CHEMBL543876"],"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL285123","canonicalSmiles":"N[C@H](CO)C(=O)O","inchiKey":"MTCFGRXMJLQNBG-UWTATZPHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"(D)-SERINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["(d)-serine","D-Serine"],"crossReferences":{"PubChem":["144204821","26753645","26753646","50106988","90341480"],"drugbank":["DB03929"],"chEBI":["16523"]},"childChemblIds":["CHEMBL4650463"],"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL285674","canonicalSmiles":"Clc1ccc2c(c1)C(c1ccccc1)=NCc1nncn1-2","inchiKey":"CDCHDCWJMGXXRH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"ESTAZOLAM","yearOfFirstApproval":1990,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Estazolam","Eurodin","Prosom"],"synonyms":["ABBOTT-47631","Estazolam","Estazolam civ","NSC-290818"],"crossReferences":{"DailyMed":["estazolam"],"PubChem":["144206162","50113063"],"Wikipedia":["Estazolam"],"drugbank":["DB01215"],"chEBI":["4858"]},"linkedTargets":{"rows":["ENSG00000022355","ENSG00000182256","ENSG00000011677","ENSG00000163285","ENSG00000151834","ENSG00000113327","ENSG00000186297"],"count":7},"linkedDiseases":{"rows":["EFO_0004698"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1990 and is indicated for insomnia. This drug has a black box warning from the FDA."}
{"id":"CHEMBL291338","canonicalSmiles":"O=C(Nc1ccc(Cl)c(Cl)c1)c1cc(Cl)cc(Cl)c1O","inchiKey":"SJQBHPJLLIJASD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"3,3',4',5-TETRACHLOROSALICYLANILIDE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["United States"]},"tradeNames":[],"synonyms":["3,3',4',5-tetrachlorosalicylanilide"],"crossReferences":{"PubChem":["144212390"],"chEBI":["188648"]},"description":"Small molecule drug with a maximum clinical trial phase of IV. It was withdrawn in United States."}
{"id":"CHEMBL298461","canonicalSmiles":"Clc1ccccc1Cl","inchiKey":"RFFLAFLAYFXFSW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"1,2-DICHLOROBENZENE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["1,2-Dichloro-Benzene","1,2-Dichlorobenzene"],"crossReferences":{"PubChem":["144204581","144209355","17389934"],"Wikipedia":["1,2-Dichlorobenzene"],"drugbank":["DB13963"],"chEBI":["35290"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3039529","canonicalSmiles":"C#Cc1cnc2nc(O)n(C(CC)CC)c2n1","inchiKey":"RSQGZEAXODVTOL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TIRASEMTIV","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CK-2017357","CK2017357","Tirasemtiv"],"crossReferences":{"drugbank":["DB12209"]},"linkedTargets":{"rows":["ENSG00000130595","ENSG00000101470","ENSG00000130598"],"count":3},"linkedDiseases":{"rows":["MONDO_0004976","EFO_0003876","EFO_0004991","EFO_0004265"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL3039531","canonicalSmiles":"Cc1c(F)cccc1NC(=O)Nc1ccc(Cl)c(S(=O)(=O)[C@H]2CCCNC2)c1O","inchiKey":"NGYNBSHYFOFVLS-LBPRGKRZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DANIRIXIN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Danirixin","GSK-1325756B","GSK1325756","GSK1325756B","Gsk1325756"],"crossReferences":{"drugbank":["DB11922"]},"childChemblIds":["CHEMBL4560026"],"linkedTargets":{"rows":["ENSG00000180871"],"count":1},"linkedDiseases":{"rows":["EFO_1001413","EFO_0000341","EFO_0000763","MONDO_0024355"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL303984","canonicalSmiles":"CO[C@@H]1[C@@H](OC(=O)c2ccc(C)[nH]2)[C@@H](O)[C@H](Oc2ccc3c(O)c(NC(=O)c4ccc(O)c(CC=C(C)C)c4)c(=O)oc3c2Cl)OC1(C)C","inchiKey":"FJAQNRBDVKIIKK-LFLQOBSNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHLOROBIOCIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Clorobiocin"],"crossReferences":{"Wikipedia":["Clorobiocin"],"drugbank":["DB03966"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL307739","canonicalSmiles":"CNCCc1ccc(OC(=O)C(C)C)c(OC(=O)C(C)C)c1","inchiKey":"WDKXLLJDNUBYCY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IBOPAMINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ibopamine","SB 7505"],"crossReferences":{"drugbank":["DB13316"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3137314","canonicalSmiles":"CC#CC[C@H](C)[C@H](O)/C=C/[C@@H]1[C@H]2c3cccc(CCCC(=O)O)c3O[C@H]2C[C@H]1O","inchiKey":"CTPOHARTNNSRSR-NOQAJONNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ESUBERAPROST","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["APS-314d","Aps-314d","Aps-314d free acid","BPS-314d","Esuberaprost"],"childChemblIds":["CHEMBL3137337","CHEMBL4298145"],"linkedTargets":{"rows":["ENSG00000160013"],"count":1},"linkedDiseases":{"rows":["EFO_0001361"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL321944","canonicalSmiles":"COc1ccc2ccc(C(=N)N)cc2c1-c1cnn(S(C)(=O)=O)c1","inchiKey":"KQUXAFOLFXHVQN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL321944","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03046"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3249110","canonicalSmiles":"COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(CCO)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1","inchiKey":"RGVRUQHYQSORBY-JIGXQNLBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"13-DEOXYDOXORUBICIN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["13-deoxydoxorubicin","GPX-100","Gpx-100"],"crossReferences":{"drugbank":["DB05706"]},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3301586","drugType":"Antibody","blackBoxWarning":false,"name":"CLIVATUZUMAB TETRAXETAN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Clivatucyn"],"synonyms":["Clivatuzumab tetraxetan","HPAM-4","IMMU-107","IgG-DOTA","hPAM4"],"linkedTargets":{"rows":["ENSG00000215182"],"count":1},"linkedDiseases":{"rows":["EFO_0002618","EFO_1000044"],"count":2},"description":"Antibody drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3301593","canonicalSmiles":"Nc1ccc(C#Cc2cnn3c(C(F)(F)F)cc(-c4ccc(C(F)(F)F)cc4)nc23)cn1","inchiKey":"DMJHZVARRXJSEG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DECOGLURANT","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Decoglurant","RO-4995819","RO4995819","Rg1578"],"crossReferences":{"drugbank":["DB11923"]},"linkedTargets":{"rows":["ENSG00000164082","ENSG00000198822"],"count":2},"linkedDiseases":{"rows":["MONDO_0002009"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL332958","canonicalSmiles":"Cc1ccc(S(=O)(=O)N(C)c2ccnn2-c2ccccc2)cc1","inchiKey":"KRHPBWNETCEFGS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL332958","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07670"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL333964","canonicalSmiles":"N[C@@H](Cn1cc(Br)c(=O)[nH]c1=O)C(=O)O","inchiKey":"AEKIJKSVXKWGRJ-BYPYZUCNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL333964","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04000"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3544937","canonicalSmiles":"COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCCn1ccnn1.Cl","inchiKey":"IOFHDGSCWJNVRZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ZD-4190","maximumClinicalTrialPhase":1,"parentId":"CHEMBL281872","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Zd-4190"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3545031","drugType":"Small molecule","blackBoxWarning":false,"name":"MK-1029","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Mk-1029"],"linkedTargets":{"rows":["ENSG00000183134"],"count":1},"linkedDiseases":{"rows":["MONDO_0004979"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3545076","canonicalSmiles":"Cn1cc(-c2ccc(F)c(C(F)(F)F)c2)nc1C1CCN(c2ncnc3[nH]ncc23)CC1","inchiKey":"FYXRSVDHGLUMHB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LY-2584702","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["LY 2584702","LY2584702","Ly-2584702"],"crossReferences":{"drugbank":["DB12690"]},"childChemblIds":["CHEMBL3911801","CHEMBL3909070"],"linkedTargets":{"rows":["ENSG00000108443"],"count":1},"linkedDiseases":{"rows":["EFO_1001901","EFO_0000681","EFO_0003060","EFO_0000311","EFO_0009708"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL3545190","drugType":"Unknown","blackBoxWarning":false,"name":"ISUNAKINRA","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["EBI-005","Isunakinra"],"description":"Unknown drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL3545224","canonicalSmiles":"Nc1cc(N2CCN(CCP(=O)(O)O)CC2)nc(NCC2CCC(CNCCCNC3CCCCC3)CC2)n1","inchiKey":"QLVSJMZJSABWRX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BURIXAFOR","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Burixafor","Tg-0054"],"linkedTargets":{"rows":["ENSG00000121966"],"count":1},"linkedDiseases":{"rows":["EFO_0001378","EFO_0000183","EFO_0005952","MONDO_0008315"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL3545276","drugType":"Small molecule","blackBoxWarning":false,"name":"CP-778875","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CP-778,875","CP-778875","Cp-778875"],"linkedTargets":{"rows":["ENSG00000186951"],"count":1},"linkedDiseases":{"rows":["Orphanet_309005"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3545356","drugType":"Small molecule","blackBoxWarning":false,"name":"VK5211","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["LGD-4033","Ligandrol","Vk-5211","Vk5211"],"linkedTargets":{"rows":["ENSG00000169083"],"count":1},"linkedDiseases":{"rows":["EFO_0003964"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL362811","canonicalSmiles":"N#Cc1cccc(S(=O)(=O)N2C[C@@H](O)[C@@H](Cc3ccccc3)N(Cc3ccc(O)cc3)C(=O)N2Cc2ccc(O)cc2)c1","inchiKey":"UYUWNNRWESUYOB-FIRIVFDPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL362811","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03141"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL363295","canonicalSmiles":"CC(CC(c1ccccc1)c1ccccc1)NC(C)(C)C","inchiKey":"UISARWKNNNHPGI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TERODILINE","yearOfFirstApproval":1986,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["Germany"," Spain"," United Kingdom"],"classes":["Cardiotoxicity"],"year":1991},"tradeNames":[],"synonyms":["Terodiline"],"crossReferences":{"Wikipedia":["Terodiline"],"drugbank":["DB13725"]},"childChemblIds":["CHEMBL539770"],"linkedTargets":{"rows":["ENSG00000157388","ENSG00000165995","ENSG00000157445","ENSG00000198216","ENSG00000167535","ENSG00000007402","ENSG00000081248","ENSG00000180720","ENSG00000141837","ENSG00000130433","ENSG00000182389","ENSG00000184984","ENSG00000075461","ENSG00000142408","ENSG00000100346","ENSG00000151067","ENSG00000166862","ENSG00000148408","ENSG00000105605","ENSG00000133019","ENSG00000006116","ENSG00000168539","ENSG00000102001","ENSG00000151062","ENSG00000006283","ENSG00000108878","ENSG00000075429","ENSG00000196557","ENSG00000153956","ENSG00000181072","ENSG00000067191"],"count":31},"linkedDiseases":{"rows":["HP_0000020","HP_0000103"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1986 and is indicated for urinary incontinence and polyuria. It was withdrawn in Germany,  Spain and  United Kingdom initially in 1991 due to Cardiotoxicity."}
{"id":"CHEMBL363498","canonicalSmiles":"N#Cc1cc(O)cc2cc(-c3ccc(O)cc3)oc12","inchiKey":"GGEKOZPXKBYLNK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL363498","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07198"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3701238","canonicalSmiles":"C=CC(=O)N1CC[C@H](n2nc(C#Cc3cc(OC)cc(OC)c3)c3c(N)ncnc32)C1","inchiKey":"KEIPNCCJPRMIAX-HNNXBMFYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FUTIBATINIB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Fgfr-in-1","Futibatinib","TAS-120","Tas 120","Tas-120"],"crossReferences":{"drugbank":["DB15149"]},"linkedTargets":{"rows":["ENSG00000066468","ENSG00000068078","ENSG00000077782","ENSG00000160867"],"count":4},"linkedDiseases":{"rows":["EFO_0000616","EFO_0000182","MONDO_0007254","EFO_1001968","EFO_0003060","EFO_0005221","EFO_0000311"],"count":7},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 7 investigational indications."}
{"id":"CHEMBL372638","canonicalSmiles":"N#Cc1ccc(-c2cc(C3CC4CCC3N4)cnc2F)cc1","inchiKey":"HMZQULPVMKITSP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL372638","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"Wikipedia":["Furafylline"],"drugbank":["DB14029"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3833342","drugType":"Oligonucleotide","blackBoxWarning":false,"name":"NUSINERSEN SODIUM","yearOfFirstApproval":2016,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Spinraza"],"synonyms":["Nusinersen sodium"],"crossReferences":{"DailyMed":["nusinersen%20sodium"]},"linkedTargets":{"rows":["ENSG00000205571"],"count":1},"linkedDiseases":{"rows":["EFO_0008525"],"count":1},"description":"Oligonucleotide drug with a maximum clinical trial phase of IV that was first approved in 2016 and is indicated for spinal muscular atrophy."}
{"id":"CHEMBL3833370","canonicalSmiles":"Cc1cc(O)cc(C)c1C[C@H](NC(=O)[C@H](N)CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(N)=O","inchiKey":"SFVLTCAESLKEHH-WKAQUBQDSA-N","drugType":"Protein","blackBoxWarning":false,"name":"ELAMIPRETIDE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Elamipretide","MTP 131","MTP-131","Nh2-d-arg-dmt-lys-phe-nh2","Ocuvia","RX 31","RX-31","SS 31","SS-31","Szeto-schiller peptide"],"crossReferences":{"drugbank":["DB11981"]},"childChemblIds":["CHEMBL4298161"],"description":"Protein drug with a maximum clinical trial phase of III (across all indications) and has 8 investigational indications."}
{"id":"CHEMBL3989689","canonicalSmiles":"CC(C)[C@@H](CC[C@@H](C)[C@H]1CC[C@H]2[C@H]3[C@H](CC[C@@]21C)[C@@]1(C)CC[C@H](NCCCNCCCCN)C[C@@H]1C[C@H]3O)OS(=O)(=O)O.C[C@H](O)C(=O)O.O","inchiKey":"ZPYIELFRIYUVQP-BHBJEIPNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SQUALAMINE LACTATE","maximumClinicalTrialPhase":3,"parentId":"CHEMBL444929","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MSI-1256F","Squalamine lactate","Squalamine lactate hydrate"],"linkedTargets":{"rows":["ENSG00000066230"],"count":1},"linkedDiseases":{"rows":["EFO_0009606","EFO_0001365","MONDO_0008170","EFO_0003770","MONDO_0008315"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL404215","canonicalSmiles":"OC(CCN1CCCCC1)(c1ccccc1)c1ccccc1","inchiKey":"RQXCLMGKHJWMOA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PRIDINOL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["C-238","NSC-23016","Pridinol","Pridinol mesilate"],"crossReferences":{"PubChem":["144203573","170465865","4252736","50100154","50104209","50104210","50104211","84992"],"Wikipedia":["Pridinol"],"drugbank":["DB13642"],"chEBI":["75247"]},"childChemblIds":["CHEMBL1528011"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4297438","canonicalSmiles":"O=C(O)/C=C\\C(=O)O.OC1CN(CCCOCCc2ccc3sccc3c2)C1","inchiKey":"RLUCYBFCLXANSO-BTJKTKAUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"T-817 MALEATE","maximumClinicalTrialPhase":2,"parentId":"CHEMBL4302089","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["J2.179.155E","T-817 maleate","T-817MA","T-817ma"],"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4297498","canonicalSmiles":"FC(F)(F)c1cccc(C2=CCN(CCc3ccc4ccncc4c3)CC2)c1","inchiKey":"ZXXHOPNSTZKWRI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SSR-150106","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["SSR-150106","SSR-150106XB","SSR150106","SSR150106XB","Ssr-150106","Ssr150106"],"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4297578","drugType":"Protein","blackBoxWarning":false,"name":"PEGBELFERMIN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ARX-618","BMS-986036","Bms-986036","Peg-fgf21","Pegbelfermin"],"linkedTargets":{"rows":["ENSG00000113578","ENSG00000134962"],"count":2},"linkedDiseases":{"rows":["EFO_0003095","EFO_1001249","MONDO_0005148"],"count":3},"description":"Protein drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4297610","canonicalSmiles":"C[C@H](Nc1ccc(C#N)n(C)c1=O)c1cc2cc(Cl)ccc2[nH]c1=O","inchiKey":"NEQYWYXGTJDAKR-JTQLQIEISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OLUTASIDENIB","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["FT-2102","Ft-2102","Olutasidenib"],"linkedTargets":{"rows":["ENSG00000138413"],"count":1},"linkedDiseases":{"rows":["EFO_0000198","EFO_0000222"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297760","drugType":"Oligonucleotide","blackBoxWarning":false,"name":"GIVOSIRAN","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["ALN-AS1","Givosiran"],"linkedTargets":{"rows":["ENSG00000023330"],"count":1},"linkedDiseases":{"rows":["Orphanet_100924","Orphanet_79276","Orphanet_79273"],"count":3},"description":"Oligonucleotide drug with a maximum clinical trial phase of IV (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297858","drugType":"Antibody","blackBoxWarning":false,"name":"BUDIGALIMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ABBV-181","ABBV181","Abbv-181","Budigalimab","PR-1648817"],"linkedTargets":{"rows":["ENSG00000188389"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","EFO_0006859","MONDO_0008170","EFO_0000180","EFO_0000764","EFO_0000702","MONDO_0007254","EFO_0000311","EFO_1001951"],"count":9},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 9 investigational indications."}
{"id":"CHEMBL4297869","drugType":"Unknown","blackBoxWarning":false,"name":"COAGULATION FACTOR VIIA RECOMBINANT HUMAN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Activated recombinant human factor vii","Coagulation factor viia (recombinant)","Coagulation factor viia recombinant human","Eptacog alfa (activated)","Eptacog beta (activated)","LR-769","LR769","Recombinant activated factor vii","Sevenfact"],"description":"Unknown drug with a maximum clinical trial phase of III (across all indications) and has 7 investigational indications."}
{"id":"CHEMBL4297898","drugType":"Unknown","blackBoxWarning":false,"name":"AVIDIN PERIODATE OXIDIZED","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Avidin periodate oxidized","Avidinox","Periodate oxidized avidin"],"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4297904","drugType":"Unknown","blackBoxWarning":false,"name":"BAY-1093884","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BAY-1093884","BAY1093884","Bay-1093884","Bay1093884","Befovacimab"],"linkedTargets":{"rows":["ENSG00000003436"],"count":1},"linkedDiseases":{"rows":["Orphanet_448","Orphanet_98879","Orphanet_98878"],"count":3},"description":"Unknown drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4297933","drugType":"Unknown","blackBoxWarning":false,"name":"DHES-0815A","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Dhes-0815a","Dhes0815a"],"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4298001","drugType":"Antibody","blackBoxWarning":false,"name":"CETRELIMAB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cetrelimab","JNJ-63723283","JNJ63723283","Jnj 63723283","Jnj-63723283"],"linkedTargets":{"rows":["ENSG00000188389"],"count":1},"linkedDiseases":{"rows":["EFO_0000294","EFO_0000616","EFO_0008528","EFO_0000673","EFO_0001378","EFO_0004239"],"count":6},"description":"Antibody drug with a maximum clinical trial phase of III (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL4298052","drugType":"Small molecule","blackBoxWarning":false,"name":"DEMPLATIN PEGRAGLUMER","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Demplatin pegraglumer","NC-6004","NC-6004 NANOPLATIN","Nc-6004"],"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL436","canonicalSmiles":"COc1ccc2c(C(=S)N(C)CC(=O)O)cccc2c1C(F)(F)F","inchiKey":"LUBHDINQXIHVLS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TOLRESTAT","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["Canada"," Italy"," Argentina"],"classes":["Hepatotoxicity"],"year":1996},"tradeNames":["Alderase","Alredase"],"synonyms":["AY-27,773","AY-27773","Tolrestat"],"crossReferences":{"PubChem":["144206867"],"Wikipedia":["Tolrestat"],"drugbank":["DB02383"],"chEBI":["48549"]},"linkedTargets":{"rows":["ENSG00000085662"],"count":1},"linkedDiseases":{"rows":["EFO_0000400"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for diabetes mellitus. It was withdrawn in Canada,  Italy and  Argentina initially in 1996 due to Hepatotoxicity."}
{"id":"CHEMBL437557","canonicalSmiles":"CN(C)C(=O)[C@@H]([C@H]1CC[C@H](c2ccc3ncnn3c2)CC1)[C@H](N)C(=O)N1CCC(F)(F)C1","inchiKey":"JNAZOMVWUGPITI-LNMJFAINSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL437557","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07092"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL445245","canonicalSmiles":"CCc1ccsc1-c1ccc(O)c(O)c1","inchiKey":"VXLXQOMDQVQQLA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL445245","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08718"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL447664","canonicalSmiles":"Cc1cc(Cn2nnc3c(-c4ccco4)nc(N)nc32)ccc1N","inchiKey":"HQSBCDPYXDGTCL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VIPADENANT","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BIIB-014","BIIB014","Biib014","CEB-4520","V-2006","V2006","VER-11135","VER-A-00-11","VER-A-00049","VER-A00-11","VER-A00049","VER-ADO-49","Vipadenant"],"crossReferences":{"drugbank":["DB06625"]},"childChemblIds":["CHEMBL3216899","CHEMBL461006"],"linkedTargets":{"rows":["ENSG00000128271"],"count":1},"linkedDiseases":{"rows":["MONDO_0005180"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL44793","canonicalSmiles":"O=C(/C=C/c1c(C(=O)O)[nH]c2cc(Cl)cc(Cl)c12)Nc1ccccc1","inchiKey":"WZBNEZWCNKUOSM-VOTSOKGWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GAVESTINEL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GV 150526X","GV-150526X","Gavestinel"],"crossReferences":{"drugbank":["DB06741"]},"childChemblIds":["CHEMBL419045"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL455917","canonicalSmiles":"OC(O)C(Cl)(Cl)Cl","inchiKey":"RNFNDJAIBTYOQL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHLORAL HYDRATE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Noctec","Sk-chloral hydrate"],"synonyms":["Chloral Hydrate","Chloral hydrate","Chlorali hydras","Chloralum","Cloral hydrate","NSC-3210"],"crossReferences":{"PubChem":["144205167","144207308","170465484","29215298"],"Wikipedia":["Chloral_hydrate"],"drugbank":["DB01563"],"chEBI":["28142"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL456649","canonicalSmiles":"N#Cc1cc(Cl)cc(Oc2c(Br)ccc(Cc3n[nH]c4nnccc34)c2F)c1","inchiKey":"OHQMEDBYNUAVNE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL456649","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08446"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4584965","canonicalSmiles":"Cl[TeH]1(Cl)(Cl)OCCO1.N","inchiKey":"DXZFFLRJVDZCMT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AMMONIUM TRICHLOROTELLURATE","maximumClinicalTrialPhase":2,"parentId":"CHEMBL4597200","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AS-101","AS101","Ammonium trichlorotellurate","As101","Ossirene"],"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 7 investigational indications."}
{"id":"CHEMBL459","canonicalSmiles":"C[C@](N)(Cc1ccc(O)c(O)c1)C(=O)O","inchiKey":"CJCSPKMFHVPWAR-JTQLQIEISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"METHYLDOPA","yearOfFirstApproval":1962,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Aldomet","Dopamet","Lederdopa","Medomet","Metalpha 250","Metalpha 500","Methyldopa"],"synonyms":["(-)-.alpha.-methyldopa","(s)-(-)-.alpha.-methyldopa",".alpha.-methyl-l-dopa","Alpha-methyldopa","Anhydrous methyldopa","BAYER-1440L","J9.247I","L-.alpha.-methyldopa","MK-351","Methyldopa","Methyldopa (levorotatory)","Methyldopa anhydrous","Methyldopa hydrate","Methyldopa sesquihydrate","Methyldopa, anhydrous","NSC-169916","NSC-760080"],"crossReferences":{"DailyMed":["methyldopa"],"PubChem":["11113581","124886927","144209808","50104474","8139902","90341702"],"TG-GATEs":["56"],"Wikipedia":["Methyldopa"],"drugbank":["DB00968"],"chEBI":["61058"]},"childChemblIds":["CHEMBL4063475","CHEMBL1591707"],"linkedTargets":{"rows":["ENSG00000184160","ENSG00000274286","ENSG00000150594"],"count":3},"linkedDiseases":{"rows":["MONDO_0005147","EFO_0000668","EFO_0000537"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1962 and is indicated for hypertension and has 2 investigational indications."}
{"id":"CHEMBL4594417","canonicalSmiles":"CC1(C)C(=O)N(c2ccc(C#N)c(C(F)(F)F)c2F)C(=S)N1c1ccc(CCCc2ncco2)nc1","inchiKey":"KCBJGVDOSBKVKP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GT-0918","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Gt-0918","Proxalutamide","Pruxelutamide"],"linkedTargets":{"rows":["ENSG00000169083"],"count":1},"linkedDiseases":{"rows":["EFO_0000694","MONDO_0100096","MONDO_0007254","MONDO_0008315"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4594525","drugType":"Unknown","blackBoxWarning":false,"name":"APVO-436","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["APVO-436","APVO436","Apvo-436","Apvo436"],"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4594606","drugType":"Unknown","blackBoxWarning":false,"name":"ANTI-PSGL-1 ANTIBODY SELK2","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Anti-psgl-1 antibody selk2","Selk2"],"description":"Unknown drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4650398","drugType":"Protein","blackBoxWarning":false,"name":"HEPALATIDE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Hepalatide"],"description":"Protein drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4802130","canonicalSmiles":"CC(C)NC(=O)COc1cccc(-c2nc(Nc3ccc4[nH]ncc4c3)c3ccccc3n2)c1.CS(=O)(=O)O","inchiKey":"ILQJXEIRBCHLOM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BELUMOSUDIL MESYLATE","yearOfFirstApproval":2021,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL2005186","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Rezurock"],"synonyms":["Belumosudil mesylate","KD025 mesylate"],"linkedTargets":{"rows":["ENSG00000134318","ENSG00000067900"],"count":2},"linkedDiseases":{"rows":["MONDO_0013730"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2021 and is indicated for graft versus host disease."}
{"id":"CHEMBL491841","canonicalSmiles":"O=C(O)c1[nH]c(C(=O)O)c(-c2c[nH]c3ccccc23)c1-c1c[nH]c2ccccc12","inchiKey":"FZDVNXHYGMEEDT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LYCOGALIC ACID A","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07588"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL500779","canonicalSmiles":"Nc1n[nH]c2ccc(-c3ccccc3)cc12","inchiKey":"ZCUSNQPYUNLATP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL500779","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07161"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL520733","canonicalSmiles":"CC(C)[C@H](O)C(=O)N[C@@H](C)C(=O)N[C@@H]1C(=O)N(C)CCc2ccccc21","inchiKey":"PKXWXXPNHIWQHW-RCBQFDQVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SEMAGACESTAT","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["LY-450139","LY450139","Semagacestat"],"crossReferences":{"Wikipedia":["Semagacestat"],"drugbank":["DB12463"]},"linkedTargets":{"rows":["ENSG00000205155","ENSG00000138613","ENSG00000162736","ENSG00000080815","ENSG00000143801","ENSG00000117362"],"count":6},"linkedDiseases":{"rows":["MONDO_0004975"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL521105","canonicalSmiles":"CCCCNC(=O)c1cccc(NC(=O)CCCCCNc2ncnc3[nH]cnc23)c1","inchiKey":"WOYITRCGMUXUDE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL521105","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07801"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL522987","canonicalSmiles":"Cc1cc(F)ccc1[C@H]1CNCCN1C(=O)N(C)[C@H](C)c1cc(C(F)(F)F)cc(C(F)(F)F)c1","inchiKey":"SBBYBXSFWOLDDG-JLTOFOAXSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VESTIPITANT","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GW-597599","Gw597599","Vestipitant"],"crossReferences":{"Wikipedia":["Vestipitant"],"drugbank":["DB11949"]},"childChemblIds":["CHEMBL2104992"],"linkedTargets":{"rows":["ENSG00000115353"],"count":1},"linkedDiseases":{"rows":["HP_0000360","MONDO_0002050","MONDO_0002009","EFO_0004888","EFO_0008568","EFO_1001917","EFO_0004698"],"count":7},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 7 investigational indications."}
{"id":"CHEMBL54277","canonicalSmiles":"O=[N+]([O-])c1ccc2cn[nH]c2c1","inchiKey":"ORZRMRUXSPNQQL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL54277","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["11113657","56423145","8139969"],"drugbank":["DB03100"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL593602","canonicalSmiles":"O=C(O)CCN1C(=O)/C(=C\\c2ccc(-c3ccc(Cl)cc3)o2)SC1=S","inchiKey":"YZLFZFALAZYTCI-NTEUORMPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL593602","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08177"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL596","canonicalSmiles":"CCC(=O)N(c1ccccc1)C1CCN(CCc2ccccc2)CC1","inchiKey":"PJMPHNIQZUBGLI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"FENTANYL","yearOfFirstApproval":1968,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Abstral","Actiq","Breakyl","Duragesic","Duragesic-100","Duragesic-12","Duragesic-25","Duragesic-37","Duragesic-50","Duragesic-75","Durogesic","Durogesic dtrans","Effentora","Fencino","Fentalis reservoir","Fentanyl-100","Fentanyl-12","Fentanyl-25","Fentanyl-37","Fentanyl-50","Fentanyl-62","Fentanyl-75","Fentanyl-87","Fentora","Ionsys","Leptanal","Matrifen","Mezolar matrix","Mylafent","Opiodur","Oralet","Osmach","Osmanil","Pecfent","Recivit","Sublimaze","Subsys","Tilofyl","Victanyl","Yemex"],"synonyms":["AD 923","AD-923","Abstral-","Durogesic d-trans","EN-3267","En3267","Fendrop","Fentanest","Fentanyl","Fentanyl cii","Fentora","IDS-NF-001","Innovar","Ionsys","N02AB03","Phentanyl","R 4263","Recuvyra","Sublimase"],"crossReferences":{"DailyMed":["fentanyl","fentanyl%20citrate"],"PubChem":["144206164","50113065"],"Wikipedia":["Fentanyl"],"drugbank":["DB00813"],"chEBI":["119915"]},"childChemblIds":["CHEMBL688","CHEMBL1201159"],"linkedTargets":{"rows":["ENSG00000112038"],"count":1},"linkedDiseases":{"rows":["EFO_1001139","EFO_0003777","HP_0012735","EFO_0000555","EFO_0003964","EFO_0009727","HP_0100543","EFO_0003931","EFO_0008585","EFO_0003884","MONDO_0021666","EFO_0004616","EFO_0004244","HP_0003419","EFO_0009620","EFO_0009870","EFO_0005762","EFO_0002618","EFO_0001074","HP_0002093","HP_0012532","EFO_0005323","MONDO_0008315","EFO_0000546","EFO_0001422","HP_0002045","EFO_0003841","MONDO_0100096","EFO_0009842","EFO_0004888","HP_0001336","EFO_0004209","EFO_0000341","HP_0025428","EFO_0003767","EFO_0005251","EFO_0006834","EFO_1001905","EFO_0004992","MONDO_0007254","EFO_1000644","EFO_0009267","EFO_1000637","EFO_0002950","EFO_1000783","MONDO_0001056","MONDO_0005277","MONDO_0002050","EFO_0007202","EFO_0003030","EFO_0000616","HP_0002094","EFO_0000685","EFO_0009508","EFO_0004210","MONDO_0021204","EFO_0001645","HP_0002571","HP_0011110","EFO_0000232","EFO_1001267","EFO_0001073","EFO_0003843","HP_0002315","EFO_0000311","EFO_0000713","EFO_0001421","EFO_0004273","EFO_1001373","EFO_0005611","MONDO_0043510","EFO_0003918","MONDO_0005178"],"count":73},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1968 and has 5 approved and 34 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL64545","canonicalSmiles":"CN(C)CCOC(=O)COc1ccc(Cl)cc1","inchiKey":"XZTYGFHCIAKPGJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MECLOFENOXATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ANP-235","Analux","Centrophenoxine","Cetrexin","Clophenoxate","Meclofenoxane","Meclofenoxate","Meclofenoxate hydrochloride","NSC-169411","Proseryl"],"crossReferences":{"PubChem":["11110999","11111000","50110990","90341454"],"drugbank":["DB13758"],"chEBI":["6712"]},"childChemblIds":["CHEMBL1256131"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL73148","canonicalSmiles":"NC(=O)N(O)CCC#C[C@@H]1CC[C@@H](COc2ccc(F)cc2)O1","inchiKey":"YANONWCPCKIWEC-CABCVRRESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CMI-977","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CMI-977"],"crossReferences":{"drugbank":["DB05431"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL80257","canonicalSmiles":"O=C(O)[C@H]1CCCN1","inchiKey":"ONIBWKKTOPOVIA-SCSAIBSYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"D-PROLINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["D-Proline","Pyrrolidine-2-Carboxylic Acid"],"crossReferences":{"PubChem":["26756694"],"drugbank":["DB02853"],"chEBI":["16313"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL9","canonicalSmiles":"CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21","inchiKey":"OGJPXUAPXNRGGI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"NORFLOXACIN","yearOfFirstApproval":1986,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Baccidal","Chibroxin","Noroxin","Quinabic","Utinor"],"synonyms":["MK-366","NSC-757250","Norfloxacin","Noroxin"],"crossReferences":{"PubChem":["11112831","124882669","144204233","144206991","170464769","174007429","26746929","855614"],"Wikipedia":["Norfloxacin"],"drugbank":["DB01059"],"chEBI":["100246"]},"childChemblIds":["CHEMBL4635810"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1986 and is indicated for bacterial disease and eye infection and has 6 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL968","canonicalSmiles":"CCN(CC)CCN1C(=O)CN=C(c2ccccc2F)c2cc(Cl)ccc21","inchiKey":"SAADBVWGJQAEFS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"FLURAZEPAM","yearOfFirstApproval":1970,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Dalmane","Flurazepam","Insumin"],"crossReferences":{"DailyMed":["flurazepam%20hydrochloride"],"PubChem":["144205754","170465018","26757995"],"Wikipedia":["Flurazepam"],"drugbank":["DB00690"]},"childChemblIds":["CHEMBL3989724"],"linkedTargets":{"rows":["ENSG00000022355","ENSG00000182256","ENSG00000011677","ENSG00000113327","ENSG00000163285","ENSG00000151834","ENSG00000186297"],"count":7},"linkedDiseases":{"rows":["MONDO_0005090","MONDO_0002050","HP_0000726","EFO_0005230","EFO_0004698"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1970 and is indicated for insomnia and has 5 investigational indications. This drug has a black box warning from the FDA."}
